Videos

Pharmacy performance measures allow the pharmacy to be more engaged in the patient's care that focuses on outcomes.

There are many initiatives that are going on at PQA right now that are related to health equity.

Ibalizumab-uiyk (Trogarzo, Theratechnologies) is an injectable CD4-directed post-attachment HIV-1 inhibitor for the treatment of HIV type 1 infection in heavily treatment-experienced adults.

The guide is an opportunity to just catalog what else is going on there to kind of be an inspiration for expansion of services.

Agnieszka Sekula and Prash Puspanathan, MD, co-founders of Enosis Therapeutics, discuss the impact of therapeutic environment on the pharmaceutical effects of psychedelics.

Experts discuss the role of pharmacists in improving screening rates for breast cancer, how they can support patients, and improve outcomes.

The goals of the pharmacy measures are ultimately to be used in value based arrangements.

Nakia Eldridge, PharmD, MBA, director of health care quality, safety, and information at US Pharmacopeia (USP), discusses points of note regarding USP’s work in setting and supporting public quality standards.

There are other courses available on HIV, but PQA's surveys the 13 medication related quality measures out there for HIV.

The term "value" is used interchangeably across our healthcare system.

The panel offers effective practices to establish value-based and pathway-driven care for patients with MPNs.

Dr Haumschild leads a discussion about maximizing the impact of care through electronic medical record (EMR) utilization.

One of PQA's quantitative research projects that they are working on now is looking at how medication adherence is related to outcomes.

Aklilu Tedla, vice president of strategy and business development at Cardinal Health, discusses the cell and gene therapies in the pipeline for approval by the FDA.

PQA's program is focused on quality measurement and improving the safe and appropriate use of medications.

Aklilu Tedla, vice president of strategy and business development at Cardinal Health, discusses the future of pharmacies as more cell and gene therapy products become available to patients.

PQA is working on developing measures specifically for evaluating pharmacy performance measurement.

Neil Lund, senior advisor, Avelere Health and Ryan Urgo, managing director, Health Policy, Avelere Health, discuss the impact of President Biden’s health care agenda on the pharmacy field.

Doug Long, vice president, Industry Relations, IQVIA, discusses notable trends reshaping specialty pharmaceutical channels and the impact of these developments on the role of the pharmacist in the health care team.

The SDOH resource guide focuses on services specific to the pharmacy and pharmacists.

The PQA team is diverse, and they have expertise in quantitative research as well as quality.

These measures are specified for application to pharmacies, as opposed to health plan measures.

Joel Wayment, vice president of operations for 3PL Services at Cardinal Health, discusses how the pharmaceutical supply chain currently manages the transport of CAR T products to sites of administration.

Ray Tancredi, divisional vice president of Specialty Pharmacy, Development & Brand Rx/Vaccine Purchasing at Walgreens, discusses blockbuster drugs in the oncology space that have been approved this year or may be hitting the market soon.

Tracy Russell, senior director, State Government Affairs at CoverMyMeds, discusses state and federal legislation that may be impacting the future of specialty pharmacies and the patient care they deliver.

Cara McNulty, president of Behavioral Health and Mental Well-Being at CVS Health, discusses a recently published survey from CVS Health Study on rising concerns of mental health in Americans.

In an interview with Pharmacy Times, Amy Pfeifer, PharmD, BCPS, CSP, of AllianceRx Walgreens Prime, discussed the important role that pharmacists can play in the treatment of prostate cancer.

Pharmacy specialists illustrate the benefits of using a comprehensive team for care delivery to patients with MPNs.

Highlighted are proposed solutions for current barriers to care for MPNs.

Sneha Sharma, director, specialty clinical solutions at Magellan Health, discusses some trends in the rare disease space that she recommends pharmacists keep an eye on this year.